Search - tctmd.com

Displaying 681 - 700 of 1218

Sort: Relevancy | Date

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

Presentation Controversies and Advances 2019

How should we really manage functional mitral regurgitation?

Presenter: Michele Hamilton

November 15, 2019

Presentation Cardiovascular Interventions 2019

Transcatheter Mitral Repair and Replacement: Data, Devices, and Patient Selection

Presenter: Matthew J. Price

November 01, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: Georg Nickenig

September 28, 2019

Presentation TCT 2019

TRUE Registry: A New Prognostic Risk Score for Risk Stratification of Patients With Severe Tricuspid Regurgitation

Presenter: Alexander Lauten

September 28, 2019

Presentation TCT 2019

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

Presenter: Rebecca Hahn

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

Presentation TCT 2019

Trial Design for Tricuspid Devices: Perspectives From the FDA

Presenter: Jaime Raben

September 28, 2019

Presentation TCT 2019

Emerging Catheter-Based Therapies: Thinking Outside the Box

Presenter: Francesco Maisano

September 28, 2019

Presentation TCT 2019

Step-by-Step Tricuspid Clipping: Echo and Intervention Working Together

Presenter: Richard Bae

September 28, 2019

Presentation TCT 2019

Transcatheter TR Therapies: Lessons Learned From the International TriValve Registry

Presenter: Maurizio Taramasso, MD

September 28, 2019

Advertisement

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

How should we really manage functional mitral regurgitation?

Transcatheter Mitral Repair and Replacement: Data, Devices, and Patient Selection

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

TRUE Registry: A New Prognostic Risk Score for Risk Stratification of Patients With Severe Tricuspid Regurgitation

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Trial Design for Tricuspid Devices: Perspectives From the FDA

Emerging Catheter-Based Therapies: Thinking Outside the Box

Step-by-Step Tricuspid Clipping: Echo and Intervention Working Together

Transcatheter TR Therapies: Lessons Learned From the International TriValve Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content